p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast
- 31 January 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (1), 39-44
- https://doi.org/10.1016/s0959-8049(96)00368-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 proteinHuman Pathology, 1993
- Heterogeneity of ductal carcinomain situ of the breastJournal of Cellular Biochemistry, 1993
- Non-invasive breast carcinomaBreast Cancer Research and Treatment, 1992
- p53 and c-erbB-2 Protein Expression in Breast Carcinomas: An Immunohistochemical Study Including Correlations with Receptor Status, Proliferation Markers, and Clinical Stage in Human Breast CancerAmerican Journal of Clinical Pathology, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissueThe Journal of Pathology, 1990
- Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysisThe Journal of Pathology, 1990
- Heterogeneity of intraductai carcinoma of the breastCancer, 1989
- P53 expression in breast cancerInternational Journal of Cancer, 1988
- Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expressionEuropean Journal of Biochemistry, 1986